- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Healthcare
Govt Releases Guidelines For Schemes To Boost Domestic Manufacturing Of Bulk Drugs, Med Devices
These schemes of the Department of Pharmaceuticals were approved by the Union Cabinet in March this year.
Read More
Telemedicine Can Help Bridge Us Gaps In The Healthcare Delivery System
Telemedicine can help us overcome the barriers to accessing healthcare services – distance between provider and patient, access to transportation, fragmented care caused due to gaps in appointments, and lack of healthcare access.
Read More
Cipla Gets India Approval To Sell COVID-19 Drug Favipiravir
The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the "urgent and unmet" need for COVID-19 treatment options in the country
Read More
'Will Leave No Stone Unturned': India To Ensure Regulatory Facilitation For Trial Of Covid Vaccine
With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) has said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.
Read More
Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
Read More
EU In Talks With Moderna, BioNtech, CureVac To Secure Possible COVID Vaccines
The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.
Read More
Infectious Disease Specialists Ask US Govt To Ensure Remdesivir Supply
"We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir," the IDSA said.
Read More
India Approves Human Trials For Second COVID-19 Vaccine Candidate
India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.
Read More
Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses
Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.
Read More
Covid-19 Vaccine Status: Here's All You Need To Know
Here is the latest update on COVID-19 vaccines from different pharmaceutical companies
Read More
BioNTech And Pfizer's COVID-19 Vaccine Shows Potential In Human Trial
The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.
Read More
Oxford COVID-19 Vaccine Developers Encouraged By Immune Response But Cautious On Timeframe
"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.
Read More
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).
Read More
Bharat Biotech Announces India's First COVID-19 Vaccine Candidate 'COVAXIN' With DCGI Approval For Human Clinical Trials
The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.
Read More
Temasek-Led Investor Group In $250 Million Vaccine Bet On Biontech
The investors are in for an early reckoning because BioNTech has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.
Read More